U.S. District Court Vacates $48 Million Arbitration Award Against OptumRx
Stories are grouped across languages, rewritten into a fixed editorial format, and linked to original sources.
TL;DR
- U.S. District Court in Florida vacated a $48 million arbitration award against OptumRx.
- The dispute involved unpaid commissions related to a 2013 agreement between UNA and OptumRx.
- The court found that the award was procured by fraud due to false claims and withheld documents by UNA.
- The original arbitration had awarded $48.3 million to UNA in October 2023.
Overview
On October 2, 2026, the U.S. District Court for the Middle District of Florida vacated a nearly $50 million arbitration award against OptumRx in a dispute with United Networks of America (UNA). The award stemmed from unpaid commissions under a 2013 agreement between the parties. The court found that the award was procured by fraud after determining that UNA had misrepresented facts concerning an alleged acquisition of a competitor, NBBI. The arbitration had originally resulted in an award of over $48 million for UNA in October 2023.
What Happened
On October 2, 2026, the U.S. District Court for the Middle District of Florida unsealed an order vacating in full a $48,362,033 arbitration award issued against OptumRx and in favor of United Networks of America (UNA).
The court, presided over by Senior Judge Timothy J. Corrigan, found clear and convincing evidence of fraudulent conduct by UNA, including withholding documents and providing false testimony during the arbitration.
The underlying dispute concerned unpaid commissions and other payments under a 2013 agreement, with UNA claiming it acquired NBBI's business, thereby entitling it to higher commissions from OptumRx. The court concluded that UNA's claim of acquiring NBBI's business was false.
Following the arbitration award in October 2023, OptumRx filed actions in both Florida and Colorado, with discovery revealing additional documents indicating fraudulent activity and resulting in court rulings, including the application of the crime-fraud exception to attorney-client privilege in the Colorado case.
Context
The dispute arose from a 2013 agreement between OptumRx, a pharmacy benefit manager, and UNA, a healthcare discount card provider, regarding commissions tied to business allegedly acquired by UNA.
Allegations of fraud, including concealment of documents and backdating agreements involving UNA and NBBI, ultimately led to the Florida court's decision to vacate the award.
Why It Matters
- The case highlights the rare circumstance in which a U.S. federal court will vacate an arbitration award for fraud.
- This decision concerns a significant amount and may impact future healthcare contractual disputes involving claims of fraudulent inducement.
- Vacating such a large award underscores the importance of honest disclosures and discovery in arbitral proceedings.